Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing GPCR-targeted small-molecule therapies for neurological diseases (programs include LP352 and LP659). The company is headquartered in La Jolla, California and is listed on the NASDAQ under the ticker LBPH.